Aduro Biotech (ADRO) Reports Q3 Loss, Misses Revenue Estimates - Zacks.com

Zacks.com
Aduro Biotech (ADRO) Reports Q3 Loss, Misses Revenue Estimates
Zacks.com
Aduro Biotech (ADRO - Free Report) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items.
Aduro Biotech Reports Third Quarter 2018 Financial ResultsGlobeNewswire (press release)
Aduro BioTech (ADRO) Announces Quarterly Earnings Results ...Fairfield Current
Fac